DK1140898T3 - Amid- og urinstofderivater som 5-HT-reuptake-inhibitorer og som 5-HT1B/1D-ligander - Google Patents
Amid- og urinstofderivater som 5-HT-reuptake-inhibitorer og som 5-HT1B/1D-liganderInfo
- Publication number
- DK1140898T3 DK1140898T3 DK98966851T DK98966851T DK1140898T3 DK 1140898 T3 DK1140898 T3 DK 1140898T3 DK 98966851 T DK98966851 T DK 98966851T DK 98966851 T DK98966851 T DK 98966851T DK 1140898 T3 DK1140898 T3 DK 1140898T3
- Authority
- DK
- Denmark
- Prior art keywords
- ht1b
- amide
- urea derivatives
- ligands
- reuptake inhibitors
- Prior art date
Links
- 102100027499 5-hydroxytryptamine receptor 1B Human genes 0.000 title abstract 2
- 101710138639 5-hydroxytryptamine receptor 1B Proteins 0.000 title abstract 2
- 150000001408 amides Chemical class 0.000 title abstract 2
- 150000003672 ureas Chemical class 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- 238000011282 treatment Methods 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 206010008120 Cerebral ischaemia Diseases 0.000 abstract 1
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 208000020358 Learning disease Diseases 0.000 abstract 1
- 208000026139 Memory disease Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 206010043118 Tardive Dyskinesia Diseases 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000006399 behavior Effects 0.000 abstract 1
- 206010008118 cerebral infarction Diseases 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 201000003723 learning disability Diseases 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Pregnancy & Childbirth (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Secondary Cells (AREA)
- Electric Double-Layer Capacitors Or The Like (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19756036A DE19756036A1 (de) | 1997-12-17 | 1997-12-17 | Amid- und Harnstoffderivate |
| PCT/EP1998/008457 WO2000037456A1 (de) | 1997-12-17 | 1998-12-22 | Amid- und harnstoffderivate als 5-ht-reuptake-inhibitoren und als 5-ht1b/1d-liganden |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1140898T3 true DK1140898T3 (da) | 2002-11-25 |
Family
ID=26042517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98966851T DK1140898T3 (da) | 1997-12-17 | 1998-12-22 | Amid- og urinstofderivater som 5-HT-reuptake-inhibitorer og som 5-HT1B/1D-ligander |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6509340B1 (es) |
| EP (1) | EP1140898B1 (es) |
| JP (1) | JP2002533333A (es) |
| CN (1) | CN1336924A (es) |
| AT (1) | ATE222903T1 (es) |
| AU (1) | AU753335B2 (es) |
| BR (1) | BR9816121A (es) |
| CA (1) | CA2355861A1 (es) |
| CZ (1) | CZ20012270A3 (es) |
| DE (2) | DE19756036A1 (es) |
| DK (1) | DK1140898T3 (es) |
| ES (1) | ES2182401T3 (es) |
| HU (1) | HUP0104878A3 (es) |
| NO (1) | NO20013086L (es) |
| PT (1) | PT1140898E (es) |
| SI (1) | SI1140898T1 (es) |
| SK (1) | SK9232001A3 (es) |
| WO (1) | WO2000037456A1 (es) |
| ZA (1) | ZA9811467B (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10252650A1 (de) * | 2002-11-11 | 2004-05-27 | Grünenthal GmbH | Cyclohexyl-Harnstoff-Derivate |
| DE10337184A1 (de) * | 2003-08-13 | 2005-03-10 | Gruenenthal Gmbh | Substituierte 3-Pyrrolidin-Indol-Derivate |
| BRPI0417858B1 (pt) * | 2003-12-23 | 2017-10-10 | H. Lundbeck A/S | Derivative compounds of aniline and pharmaceutical composition that understand it |
| GB0400895D0 (en) * | 2004-01-15 | 2004-02-18 | Smithkline Beecham Corp | Chemical compounds |
| TW200616967A (en) | 2004-06-24 | 2006-06-01 | Smithkline Beecham Corp | Novel indazole carboxamides and their use |
| AR052308A1 (es) * | 2004-07-16 | 2007-03-14 | Lundbeck & Co As H | Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto |
| AR054393A1 (es) * | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos. |
| US7629473B2 (en) * | 2005-06-17 | 2009-12-08 | H. Lundbeck A/S | 2-(1H-indolylsulfanyl)-aryl amine derivatives |
| US8063071B2 (en) | 2007-10-31 | 2011-11-22 | GlaxoSmithKline, LLC | Chemical compounds |
| CN100448849C (zh) * | 2006-02-02 | 2009-01-07 | 深圳市天和医药科技开发有限公司 | 一种4位-酰基取代-2-甲基哌嗪化合物的制备方法 |
| PE20081889A1 (es) | 2007-03-23 | 2009-03-05 | Smithkline Beecham Corp | Indol carboxamidas como inhibidores de ikk2 |
| EP2209380A4 (en) * | 2007-10-09 | 2011-09-14 | Mark T Hamann | METHOD OF USE OF COMPOSITIONS WITH ANTIDEPRESSIVE EFFICACY, MOOD EFFICACY AND OTHER NEUROLOGICAL EFFECTIVENESS AND COMPOSITIONS THEREOF |
| JP2012520257A (ja) | 2009-03-10 | 2012-09-06 | グラクソ グループ リミテッド | Ｉｋｋ２阻害剤としてのインドール誘導体 |
| WO2011078369A1 (ja) * | 2009-12-25 | 2011-06-30 | 持田製薬株式会社 | 新規アリールウレア誘導体 |
| US9102669B2 (en) | 2011-12-06 | 2015-08-11 | Janssen Pharmaceutica Nv | Substituted piperidinyl-pyridazinyl derivatives useful as SCD 1 inhibitors |
| WO2013085954A1 (en) * | 2011-12-06 | 2013-06-13 | Janssen Pharmaceutica Nv | Substituted piperidinyl-carboxamide derivatives useful as scd 1 inhibitors |
| UY36390A (es) * | 2014-11-05 | 2016-06-01 | Flexus Biosciences Inc | Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen |
| EP3215141A4 (en) | 2014-11-05 | 2018-06-06 | Flexus Biosciences, Inc. | Immunoregulatory agents |
| WO2020011731A1 (en) * | 2018-07-12 | 2020-01-16 | UCB Biopharma SRL | Spirocyclic indane analogues as il-17 modulators |
| WO2020183011A1 (en) | 2019-03-14 | 2020-09-17 | Institut Curie | Htr1d inhibitors and uses thereof in the treatment of cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2084531A1 (en) | 1991-12-19 | 1993-06-20 | David W. Smith | Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines |
| FR2740134B1 (fr) * | 1995-10-18 | 1998-01-09 | Pf Medicament | Derives d'amines cycliques d'aryl-piperazines, leur preparation et les compositions pharmaceutiques les contenant |
| DE19615232A1 (de) * | 1996-04-18 | 1997-10-23 | Merck Patent Gmbh | Neue Carbamoylderivate und deren Verwendung als 5-HT ¶1¶¶A¶-Antagonisten |
-
1997
- 1997-12-17 DE DE19756036A patent/DE19756036A1/de not_active Withdrawn
-
1998
- 1998-12-14 ZA ZA9811467A patent/ZA9811467B/xx unknown
- 1998-12-22 PT PT98966851T patent/PT1140898E/pt unknown
- 1998-12-22 JP JP2000589528A patent/JP2002533333A/ja active Pending
- 1998-12-22 BR BR9816121-0A patent/BR9816121A/pt not_active IP Right Cessation
- 1998-12-22 EP EP98966851A patent/EP1140898B1/de not_active Expired - Lifetime
- 1998-12-22 DK DK98966851T patent/DK1140898T3/da active
- 1998-12-22 US US09/868,840 patent/US6509340B1/en not_active Expired - Fee Related
- 1998-12-22 WO PCT/EP1998/008457 patent/WO2000037456A1/de not_active Application Discontinuation
- 1998-12-22 AU AU25140/99A patent/AU753335B2/en not_active Ceased
- 1998-12-22 SI SI9830281T patent/SI1140898T1/xx unknown
- 1998-12-22 CA CA002355861A patent/CA2355861A1/en not_active Abandoned
- 1998-12-22 SK SK923-2001A patent/SK9232001A3/sk unknown
- 1998-12-22 HU HU0104878A patent/HUP0104878A3/hu unknown
- 1998-12-22 AT AT98966851T patent/ATE222903T1/de not_active IP Right Cessation
- 1998-12-22 DE DE59805363T patent/DE59805363D1/de not_active Expired - Fee Related
- 1998-12-22 ES ES98966851T patent/ES2182401T3/es not_active Expired - Lifetime
- 1998-12-22 CN CN98814399A patent/CN1336924A/zh active Pending
- 1998-12-22 CZ CZ20012270A patent/CZ20012270A3/cs unknown
-
2001
- 2001-06-21 NO NO20013086A patent/NO20013086L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20013086D0 (no) | 2001-06-21 |
| AU753335B2 (en) | 2002-10-17 |
| AU2514099A (en) | 2000-07-12 |
| DE19756036A1 (de) | 1999-06-24 |
| ATE222903T1 (de) | 2002-09-15 |
| BR9816121A (pt) | 2001-11-13 |
| NO20013086L (no) | 2001-08-21 |
| CN1336924A (zh) | 2002-02-20 |
| CZ20012270A3 (cs) | 2001-12-12 |
| WO2000037456A1 (de) | 2000-06-29 |
| JP2002533333A (ja) | 2002-10-08 |
| CA2355861A1 (en) | 2000-06-29 |
| SK9232001A3 (en) | 2001-12-03 |
| EP1140898B1 (de) | 2002-08-28 |
| US6509340B1 (en) | 2003-01-21 |
| ES2182401T3 (es) | 2003-03-01 |
| EP1140898A1 (de) | 2001-10-10 |
| PT1140898E (pt) | 2003-01-31 |
| ZA9811467B (en) | 1999-06-14 |
| SI1140898T1 (en) | 2003-02-28 |
| HUP0104878A2 (hu) | 2002-04-29 |
| HUP0104878A3 (en) | 2003-01-28 |
| DE59805363D1 (de) | 2002-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1140898T3 (da) | Amid- og urinstofderivater som 5-HT-reuptake-inhibitorer og som 5-HT1B/1D-ligander | |
| MY132794A (en) | Piperazine derivatives | |
| DE69833451D1 (de) | Behandlung der schizophrenie mit ampakinen und neuroleptika | |
| NO20031794D0 (no) | Nye forbindelser | |
| SE9900100D0 (sv) | New compounds | |
| DE59914814D1 (de) | Heterozyklische substituierte amide, deren herstellung und anwendung | |
| MXPA02000973A (es) | Benzofurilpiperazinas y benzofurilhomopiperazinas: agonistas de serotonina. | |
| BRPI0406809A (pt) | Heterociclos substituìdos de 2-aminopiridina como inibidores da proliferação celular | |
| IS8212A (is) | Nýjar 8-aza-bísýkló[3.2.1]oktanafleiður og notkunþeirra sem mónóamín-taugaboðefnaendurupptökuhindrar | |
| TR200003004T2 (tr) | Kalpain önleyicileri olarak heterosiklik ikame edilmiş amidler | |
| DE60237725D1 (de) | Vervendung von dexrazoxane in der prävention und behandlung der alzeheimer-krankheit | |
| NO20051844L (no) | Piperazinderivater og fremgangsmate for anvendelse derav. | |
| ATE403433T1 (de) | Adenosin-a1-rezeptorantagonisten zur behandlung von hypoxiebedingten lern- und gedächtnisstörungen | |
| WO2004014869A3 (en) | 5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors | |
| PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
| NO20055749L (no) | Sulfamat benzotiofenderivater som steroid sulfatase inhibitorer | |
| ATE301474T1 (de) | Zusammensetzungen zur behandlung baktrieller infektionen, welche ein oxazolidinonderivat, sulbactam und ampicillin enthalten | |
| NO20055517L (no) | 4-,6-O 7-hydroksyindoler med N-oksidgrupper og anvendelse av disse som terapeutiske midler | |
| ECSP045145A (es) | Uso de inhibidores de la recaptacion de norepinefrina para el tratamiento del fallo cognitivo | |
| EE200300028A (et) | (R)-N-[5-metüül-8-(4-metüülpiperasiin-1-üül)-1,2,3,4-tetrahüdro-2-naftüül]-4-morfolin obensamiidi uus vorm, meetod selle saamiseks ning kasutamine | |
| WO2000069424A3 (en) | Method of treating psychotic disorders | |
| EA200301101A1 (ru) | Производные пиперазина и их применение в качестве ингибиторов pde4 | |
| WO2008096189A3 (en) | Piperidine and piperazine derivatives | |
| ATE250058T1 (de) | Crf rezeptor-antagonisten und darauf bezogene methoden | |
| IS8034A (is) | Imídasó[4,5-B]kínólínafleiður og notkun þeirra sem NO-myndunarhemla |